Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysisFlora Peyvandi, Bülent Zülfikar, Amal El‐Beshlawy et al.|Journal of Thrombosis and Haemostasis|2017Cited by 40
Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurementSilvia Spena, Bülent Zülfikar, Isabella Garagiola et al.|Journal of Thrombosis and Haemostasis|2018Cited by 33
Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practiceRoberto Castelli, Agostino Cortelezzi, Antonino Cannavò et al.|Immunopharmacology and Immunotoxicology|2012Cited by 18